Lauren Finkelstein, PhD
Postdoctoral Research Fellow, NIDA T32 Science of Co-Occurring Disorders, Center for Technology and Behavioral Health
Lauren Finkelstein is a postdoctoral fellow in the NIH-NIDA T32 Science of Co-Occurring Disorders program within Dartmouth College’s Center for Technology and Behavioral Health. She received her PhD in Clinical Psychology from the University of Colorado Boulder and completed a predoctoral fellowship in behavioral medicine at Massachusetts General Hospital/Harvard Medical School. She currently works with Dr. Madelyn Frumkin, using intensive longitudinal data techniques to develop personalized digital therapeutics that address the mental and behavioral health needs of individuals living with cancer or other chronic illnesses.
Selected Publications
- Finkelstein LB, Wojdak CP, Studts JL, Arch JJ. Writing content predicts outcomes in written exposure to worst-case scenarios for advanced cancer. J Palliat Med. 2025 Dec;28(12):1648-1653. doi: 10.1089/jpm.2024.0463. PMID: 40510017.
- Finkelstein LB, Bright EE, Gu HCJ, Arch JJ. Optimizing the use of personal values to promote medication adherence: a randomized controlled trial comparing affective and behavioral responses to theory-driven domain congruent versus incongruent values approaches. Ann Behav Med. 2025 Jan 4;59(1):kaae064. doi: 10.1093/abm/kaae064. PMID: 39425763.
- Arch JJ, Kirk MH, Finkelstein LB. Patient-reported worst-case scenarios in advanced cancer: presence, contents, and predictors. Psychooncology. 2024 Dec;33(12):e70039. doi: 10.1002/pon.70039. PMID: 39710501; PMCID: PMC12306500.
- Arch JJ, Slivjak ET, Finkelstein LB. A novel intervention to reduce fear of progression and trauma symptoms in advanced cancer using written exposure to worst-case scenarios. J Palliat Med. 2024 Aug;27(8):1009-1017. doi: 10.1089/jpm.2023.0658. PMID: 38579139.
- Arch JJ, Bright EE, Finkelstein LB, Fink RM, Mitchell JL, Andorsky DJ, Kutner JS. Anxiety and depression in metastatic cancer: a critical review of negative impacts on advance care planning and end-of-life decision making with practical recommendations. JCO Oncol Pract. 2023 Dec;19(12):1097-1108. doi: 10.1200/OP.23.00287. PMID: 37831973; PMCID: PMC10732500.
- Bright EE, Finkelstein LB, Nealis MS, Genung SR, Wrigley J, Gu HCJ, Schmiege SJ, Arch JJ. A systematic review and meta-analysis of interventions to promote adjuvant endocrine therapy adherence among breast cancer survivors. J Clin Oncol. 2023 Oct 1;41(28):4548-4561. doi: 10.1200/JCO.23.00697. PMID: 37531593; PMCID: PMC10553065.
- Finkelstein LB, Friedman NP, Arch JJ. Anxiety trajectories among cancer survivors during the COVID-19 pandemic. J Psychosoc Oncol. 2023;41(5):558-583. doi: 10.1080/07347332.2022.2154187. PMID: 36655572; PMCID: PMC10354221.
- Finkelstein LB, Fishbein JN, Bright EE, Nealis M, Schmiege SJ, Arch JJ. Cancer survivors' cancellations of healthcare appointments during the COVID-19 pandemic: Associations with anxiety and depression. Psychooncology. 2022 Dec;31(12):2104-2112. doi: 10.1002/pon.6044. PMID: 36209390; PMCID: PMC9874902.